PTC Therapeutics, Inc. (PTCT)
Market Closed
16 Oct, 08:00 PM
$
59. 24
-1.75
-2.8693%
$
5.4B Market Cap
- P/E Ratio
- Div Yield
789,000 Volume
-5.84 Eps
$ 60.99
Previous Close 
Want to track PTCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PTC Therapeutics, Inc. (PTCT) Statistics
Valuation metrics
Market Cap 5.4B
Enterprise value 4.59B
Trailing P/E (ttm) -120.9
Forward P/E -
PEG ratio 0.8
Price/Sales (ttm) 4.9
Price/Book (mrq) -29.74
Enterprise Value/Revenue 4.55
Enterprise Value/EBITDA 26.46
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.07M
Average volume (90 days) 1.12M
Price summary
52-Week low 58.8
52-Week high 90.87
Beta -
50-Day moving average 65.37
200-Day moving average 71.61
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.04%
Operating margin 0.12%
Operational effectiveness
Return on assets -0.01%
Return on equity 0.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 12.15
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.46
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 26.85
Total debt (mrq) -
Total Debt/Equity (mrq) -4.21
Current ratio (mrq) 3.39%
Book value per share (mrq) -1.99
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
